Another interesting finding in this study was that the development of depression-like phenotypes after prenatal exposure to a supra-therapeutic dose of buprenorphine was accompanied by decreased circulating levels of BDNF and serotonin, TrkB phosphorylation, and CREB activity. Here, NTRK2 is linked to depressive symptom measurement.